Organoid-based HTS/HCS integrated System

• 
• MBD　
• 
• 12-09　
• 
• 84　

1. 32,000 samples screening per day

2. High reproducibility and short trunaround time

3. No cross-contamination and human error-free system

4. Resouce cost-saving and labor-free process

5. Various applications: CCRT screening / Co-culture method for immunotherapy

6. FDA & CE certifications

MBD HTS system.pdf (2.5M)